Literature DB >> 10425821

[Risk factors related to mortality in newborns with stage III necrosing enterocolitis].

M A Rivera-Moreno1, J A Mercado-Arellano, A Ulloa-Ricardez, M Franco-Gutiérrez.   

Abstract

BACKGROUND: The aim of this study was to identify risk factors associated to mortality in newborn stage III necrotizing enterocolitis (NEC III).
SETTING: Neonatal Intensive Care Unit (NICU) at the Hospital de Pediatría CMN Siglo XXI IMSS; Mexico City.
METHODS: Twenty one clinical records were analyzed. A case-control study was realized from patients admitted in the NICU from January to November 1997.
RESULTS: Two cases were excluded. The 19 that remained had 52% mortality. They were ten cases and nine controls. They were no significant differences between both groups in gestational age, birth weight, breast or formula feeding, neither X-rays nor whíte blood cells and platelet counts showed differences, except in band-count increase. Anterior abdominal wall celullitis and gut perforation, both had significative differences (p = 0.01); also shock and acute renal failure had an odds ratio of 11.2 and 72, respectively.
CONCLUSIONS: The NEC mortality in this study is similar to previous communications; nevertheless, the gestational age of these patients is greater than the literature reports. The most significant risk factors found in this paper in relationship to mortality were shock and acute renal failure; both had a high odds ratio.

Entities:  

Mesh:

Year:  1999        PMID: 10425821

Source DB:  PubMed          Journal:  Gac Med Mex        ISSN: 0016-3813            Impact factor:   0.302


  2 in total

1.  Factors associated with mortality in acute renal failure (ARF) in children.

Authors:  Reyner Loza; Luis Estremadoyro; César Loza; Javier Cieza
Journal:  Pediatr Nephrol       Date:  2005-10-27       Impact factor: 3.714

2.  Differences in the Clinical Characteristics of Early- and Late-Onset Necrotizing Enterocolitis in Full-Term Infants: A Retrospective Case-Control Study.

Authors:  Qiu-Yu Li; Yao An; Li Liu; Xue-Qiu Wang; Shi Chen; Zheng-Li Wang; Lu-Quan Li
Journal:  Sci Rep       Date:  2017-02-17       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.